research use only
Cat.No.P1105
Amino-acid Sequence
CAS No. 2012558-47-1
Sellecks Bulevirtide (Myrcludex B) Has Been Cited by 1 Publication
| Storage (from the date of receipt) | 3 years-20°C powder | ||
|
In vitro |
DMSO
: 100 mg/mL
(18.52 mM);
Water : 50 mg/mL |
Molecular Weight Calculator |
|
In Vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | Bulevirtide (Myrcludex B) is a sodium-taurocholate co-transporting polypeptide (NTCP) receptor inhibitor with IC50 of ~80 pM and inactivates NTCP function at concentrations far below those required to block bile salt transport. |
|---|---|
| Targets/IC50/Ki |
NTCP
|
In vitro |
||||
| In vitro | Bulevirtide (Myrcludex B) is a sodium-taurocholate co-transporting polypeptide (NTCP) receptor inhibitor with IC50 of ∼80 pM and inactivates NTCP function at concentrations far below those required to block bile salt. transport. |
|||
|---|---|---|---|---|
| Cell Research | Cell Lines | U2OS cells | ||
| Concentrations | 200 nM | |||
| Incubation Time | 1 h | |||
| Method | Cells were treated with indicated concentration of drug for 1 h. |
|||
References |
|
| Molecular Formula | C248H355N65O72 |
|---|---|
| Molecular Weight | 5398.86 |
| CAS No. | 2012558-47-1 |
| Appearance | White Powder |
| Peptide Content (by %N) | ≥80% |
| Single Impurity (by HPLC) | ≤1.0% |
| Assay (By Anhydrous, Acetic Acid-free) | 95.0~105.0% |
| MS | Consistent |
| Packing | plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. |
| Storage (From the date of receipt) |
3 years-20°C powder |
| Shipping | Room temperature shipping (Stability testing shows this product can be shipped without any cooling measures.) |